Institutional Cluster

APLS

Apellis Pharmaceuticals, Inc.
MIXED
Impact 6/10
Horizonweeks Processed6mo ago
Institutional cluster: 2 buyers, 3 sellers (mixed)
Actionable Insight ◆ Mixed

Monitor for upcoming clinical data readouts or regulatory decisions; the strong passive inflows may reflect positioning for a potential rebound, while quant outflows suggest risk-off behavior or model-driven exits.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+20d
APLS ▲ +141.31% at T+20d
NEUTRAL call ✓ call won +141.31% · α vs SPY +128.57% · entry $16.97 → $40.95
Next anchor: T+60d due 3mo ago
Latest observation: T+34 +97.46% FF3 residual α
Entry anchored
Mar 26, 03:59 PM ET
via exchange tick
T+1d
+0.71%
call +0.71% · α +1.06%
$17.09
settled 6mo ago
T+5d
+139.42%
call +139.42% · α +135.56%
$40.63
settled 6mo ago
T+20d
+141.31%
call +141.31% · α +128.57%
$40.95
settled 5mo ago
T+60d
—
call — · α —
—
due 3mo ago

Executive Summary

In Q4 2024, Apellis Pharmaceuticals (APLS) saw a mixed institutional cluster: two mega-passive firms (UBS and Morgan Stanley) significantly increased holdings by $282.5M, while three institutions (Wells Fargo, RenTech, Citadel) reduced positions by $8.8M. The divergence suggests conflicting views on valuation or upcoming catalysts.

Key Financial Metrics

Direction
mixed
Buy Value
$282.5M
Sell Value
$8.8M
Net Flow
$273.7M

Institutional Positions

Net institutional flow: $273.7M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
UBSDOUBLED+688.2%$82.5M$73.1M
Morgan StanleyDOUBLED+184%$307.2M$209.4M

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Wells FargoNEAR_EXIT-96%$4.0M-$3.8M
RenTechTRIM-27%$10.7M-$2.1M
CitadelTRIM-27.2%$15.1M-$2.9M

Key Facts

  • UBS doubled its position in APLS, increasing value by $73.1M (+688.2% in shares).
  • Morgan Stanley added $209.4M to its position, increasing shares by 184%.
  • Wells Fargo nearly exited, reducing its stake by 96% (-$3.8M in value).
  • Quant funds RenTech and Citadel each trimmed positions by ~27% (-$5.0M combined).
  • Total institutional buying: $282.5M; total selling: $8.8M.

Financial Impact

2 institutions accumulated $282.5M in new/expanded positions while 3 reduced holdings by $8.8M

market_sentimentinstitutional_confidencefloat_distribution

Risk Factors

  • Heavy selling by quant funds could indicate technical or momentum-based deterioration.
  • Near-complete exit by Wells Fargo may reflect fundamental concerns or portfolio rebalancing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-APLS-2024-Q4
5 reports for APLS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for APLS — sortable, filterable
TypeNow
May 26, 2026
18w ago
15-12G
NEUTRAL ★ 6/10
—awaiting T+1——
May 14, 2026
20w ago
25-NSE
NEUTRAL ★ 2/10
$41.03 $41.03· 0.00%▲ +1.23%—
May 14, 2026
20w ago
8-K
BULLISH ★ 8/10
$41.03 $41.03· 0.00%▲ +1.23%—
May 4, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$40.97 $40.97· 0.00%▼ −0.80%—
Mar 27, 2026
27w ago
Institutional Cluster
MIXED ★ 6/10
$16.97 $17.09▲ +0.71%▲ +1.06%—
Showing 5 of 5

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 27, 2026